NBC News - July 30, 2022
Ulrich Jorde, M.D., says the first HIV-positive to HIV positive heart transplant, performed at Montefiore, is a milestone in the history of organ donation. Dr. Jorde is professor of medicine at Einstein and head of heart failure, cardiac transplantation & mechanical circulatory support and vice chief of the division of cardiology at Montefiore.
Dr. Jorde's Profile
BronxNet - July 27, 2022
Balazs Halmos, M.D., discusses a grant that will enable the Montefiore Einstein Cancer Center to improve lung cancer care for underserved minority patients. Dr. Halmos is professor of medicine at Albert Einstein College of Medicine and associate director of clinical science at the Montefiore Einstein Cancer Center.
Dr. Halmos' ProfileMore coverage on Dr. Halmos
Medscape - July 26, 2022
Robert Grossberg, M.D., comments on an analysis that found certain anti-viral treatments for COVID-19 may help patients avoid hospitalization or death, but notes that the studies were done only in unvaccinated participants and before the Omicron variant emerged. Dr. Grossberg is associate professor of medicine at Einstein and an infectious disease physician at Montefiore.
Dr. Grossberg's Profile
Medscape - July 25, 2022
Matthias Eikermann, M.D., discusses his study that found that patients who identified as Black versus those who identified as white have a higher risk of adverse discharge to a nursing home after surgery. Dr. Eikermann is professor and chair of anesthesiology at Einstein and Montefiore. chair of anesthesiology at Montefiore.
Dr. Eikermann's Profile
Medscape - July 20, 2022
Dawn Buse, Ph.D., leads a discussion on the effects of stigma against people who have chronic migraine and ways that physicians and patients can address stigmatizing attitudes through advocacy and education. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology at Einstein.
Dr. Buse's ProfileMore coverage on Dr. Buse
MedPageToday - July 8, 2022
Eric Hollander, M.D., discusses results of a large, randomized clinical trial that found the drug balovaptan did not improve socialization and communication among those with pediatric autism spectrum disorder (ASD). Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore and Einstein.
Additional coverage includes Medscape
Dr. Hollander's ProfileMore coverage on Dr. Hollander
The City - July 5, 2022
Antoinette Danvers, M.D., explains the importance of abortion training and Montefiore and Einstein's efforts to offer it to medical residents in states where abortion is now illegal. Dr. Danvers is associate professor of obstetrics & gynecology and women's health at Einstein and director of the division of complex family planning at Montefiore.
Dr. Danvers' Profile
MedPageToday - July 1, 2022
In a MedPage Today commentary, Einstein medical students Sarah McNeilly and Vivian Kim call for national organizations overseeing medical education to implement a universal curricular standard for abortion education.
Academic Minute - June 22, 2022
Steven Walkley, D.V.M., Ph.D., describes "gene teams" at Einstein and Montefiore in which physicians and scientists provide clinical information and research updates to parents of children diagnosed with rare genetic diseases. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology.
Dr. Walkley's ProfileMore coverage on Dr. Walkley
MedPageToday - June 19, 2022
Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The Scientist - June 16, 2022
Meredith Hawkins, M.D., M.S., explains her study that describes a metabolically distinct type of diabetes characterized by low body weight and problems with insulin secretion—a crucial step toward developing effective treatments. Dr. Hawkins is the founding director of the Global Diabetes Institute, professor of medicine, and the Harold and Muriel Block Chair in Medicine at Einstein.
Additional coverage includes UPI and The Hindu
Dr. Hawkins' ProfileMore coverage on Dr. Hawkins
Medscape - June 1, 2022
Noa Schwartz, M.D., M.S., comments on the discovery of a rare mutation in a person with systemic lupus erythematosus and the possibility that it could lead to new treatments for a subset of patients with the disease. Dr. Schwartz is assistant professor of medicine at Einstein and director of the Montefiore-Einstein Institute for Lupus Care and Research.
Dr. Schwartz's Profile
CNN - May 31, 2022
Joe Verghese, M.B.B.S., M.S., comments on a study that found adults over age 65 had an increased risk of dementia if they had both a decrease in their walking speed and signs of cognitive function decline. Dr. Verghese is chief of the integrated divisions of cognitive and motor aging and of geriatrics at Einstein and Montefiore. He also is the Murray D. Gross Memorial Faculty Scholar in Gerontology, director of the Resnick Gerontology Center, and professor in the Saul R. Korey Department of Neurology and of medicine at Einstein.
Additional coverage includes MedPage Today, Medscape
Dr. Verghese's ProfileMore coverage on Dr. Verghese
Drug Discovery News - April 17, 2022
Nicholas Baker, Ph.D., discusses a study that discovered how epithelial cells interact with precancerous cells, recognizing them and removing them from the body. Dr. Baker is professor of genetics, of developmental and molecular biology, and of ophthalmology and visual sciences, and is the Harold and Muriel Block Chair in Genetics.
Dr. Baker's ProfileMore coverage on Dr. Baker
Healio - January 26, 2022
Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.
Dr. Lu's Profile
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
Dr. Ovryn's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile